Our sites:
Networks
Geos
Verticals

Facial Atopic Dermatitis and Atopic Keratoconjunctivitis (AKC) - Clinical Study [US,CA] (Email,Social,Banner,Native,Push,SEO,Search,Brand Bidding) - CPL

Active Created 2023/07/25 Updated 14 hours ago
PAYOUT
$ 125.00 CPA
CATEGORY Health
GEO
US
CA
SHARE

DESCRIPTION

Conversion Point: Valid Form Fill Ages: 18+ Gender: Any Compensation: Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $1575 for 7 visits or $2475 for 11 visits ...

SHOW MORE

RESTRICTIONS

Conversion Point: Valid Form Fill Ages: 18+ Gender: Any Compensation: Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $1575 for 7 visits or $2475 for 11 visits for time and travel. GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Qualifications: - Must currently have an active eczema rash on your face - Eczema rash must affect your eyes or eyelids - if eligible to participate, you will be asked to discontinue wearing contact lenses for the duration of the study Study Description: The purpose of this clinical study is to see how effective an investigational medication is at helping to treat a condition known as atopic keratoconjunctivitis, or AKC. AKC presents as red, itchy eyes and eye lids and is commonly seen in patients with facial eczema that affects the eyes and/or eye lids. The study medication is currently FDA approved to treat several inflammatory conditions and is being explored as a new therapy option for patients with AKC. You will be asked to attend a screening visit to determine if you are eligible to enroll in the study. If enrolled, you will receive either the injectable medication being tested in this study or a placebo to be administered every 7 days for a total of 16 weeks of treatment. Your total participation will last approximately 4 months and you will be asked to attend 7 doctor’s visits. After 4 months, participants will be offered the chance to join an optional open-label period where they will receive the study medication for up to an additional 16 weeks of treatment. Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $1575 for 7 visits or $2475 for 11 visits for time and travel. During study visits, you will complete various procedures and tests that will include visual tests, eye exams, vitals, and physical exams. The doctor’s office conducting the study will be able to provide you with more information about the study requirements.

YOU MAY LIKE

Find the best offers and take your affiliate earnings to a whole new level!

© 2012-2024 Affplus.com